Testimonials
"I have engaged Defined Health on multiple projects and always found their insights into oncology, the marketplace, emerging trends and technologies to be extremely valuable. Defined Health has a deep understanding of the science and evolving marketplace in oncology and their work has played an integral role in shaping various therapeutic and molecule strategies at Lilly."
Rod J. Taylor
Manager, Oncology New Product Planning, Eli Lilly and Company
"We are extremely pleased with the exceptional quality of the product development and commercialization strategy work that Defined Health conducted for LineaGen. Defined Health’s research was rigorous, credible and relevant, and was vital in helping LineaGen develop a clear path and forward-looking strategy."
Michael S. Paul, PhD
President and CEO of LineaGen, Inc.
"When combining complex scientific analyses with strategic considerations, Defined Health is the definitive source of the best advice. We have worked together on a broad range of projects and always encountered the same professionalism and critical insight."
Claudia Hirawat
Senior Vice President, Corporate Development
PTC Therapeutics, Inc.
“Defined Health is an invaluable, objective resource when we are making critical decisions with significant strategic and commercial implications. Their view of cancer therapeutics is insightful and their help is always informed, and up-to-date.”
Bruce J. Seeley
Executive Vice President, Commercial Development
Seattle Genetics
“We've worked with Defined Health since our start-up. They are the poster child for value-added product strategy and market analysis. They don't just tell you what you want to know, they tell you what you don't know but should.”
Clive A. Meanwell, MD, PhD
Chairman & CEO
The Medicines Company
"I have been a client of Defined Health for over 6 years, both at my present company and my previous one. I have utilized DH whenever I have projects involving complex commercialization issues, including cutting edge clinical approaches requiring keen scientific understanding. They have provided me with critical insights, in a timely fashion, that have helped our decision-making process and that have ultimately helped shape the course of some of our key development programs."
Jean-Sylvain Demelier
Vice President, Global Oncology Marketing
Bayer HealthCare Pharmaceuticals